Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(2 sites)
United States
Sibley Memorial Hospital, Washington D.C., District of Columbia Johns Hopkins University School of Medicine, Baltimore, Maryland Last updated November 2025